Study on Characteristics of Antibody from Milk Immunized with Some Helicobacter pylori Antigen

Helicobacter pylori 항원을 이용한 면역우유의 항체특성에 관한 연구

  • Park, Chang-Ho (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Ye, Eun-Ju (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Kim, Soo-Jung (Dept. of Oriental Medicine Biofood Science, Daegu Haany University) ;
  • Bae, Man-Jong (Dept. of Oriental Medicine Biofood Science, Daegu Haany University)
  • 박창호 (대구한의대학교 한방바이오식품과학과) ;
  • 예은주 (대구한의대학교 한방바이오식품과학과) ;
  • 김수정 (대구한의대학교 한방바이오식품과학과) ;
  • 배만종 (대구한의대학교 한방바이오식품과학과)
  • Published : 2005.06.01


This study has been carried out to examine the characteristics of anti-H. pylori antibodies of milk produced from cows immunized with antigen of Helicobacter pylori such as peculiarity of antigen antibody, agglutination of H. pylori strain, stability of antibody against acid, alkali and heat treatments. The molecular weight of anti-H. pylori antibody measured by SDS-PAGE were turned out as about 50 kDa in the heavy chain and about 24 kDa in the light chain. Twenty protein bands were visualized in H. pylori interacting with anti-H. pylori antibody which was made in dairy cow by immunization with H. pylori. The western blotting was peformed in order to examine the antigen peculiarity of anti-H. pylori, The results were all 7 antigen substances including serum, furified serum, whey and furified whey could be confirmed and the major antigen substances were 97, 66,34 kDa of molecular weight. As a result of agglutination response anti-H. pylori antibody in whey showed 1/10 agglutination value against H. pylori. In stability test about acid and alkali of antibody, there was $100\%$ activated at the range of $pH5\~pH10$. In stability test about heat, the antibody showed stable condition at $60^{\circ}C$ for 60 minutes and comparatively stable condition at $70^{\circ}C$, but reduced activation to $40\%$ after 60 minutes. It maintained $77\%$ activation at $80^{\circ}C$ for 4 minutes and comparatively stable at $100^{\circ}C$ for 1 minute.


  1. Marshall BJ, Warren JR. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 323: 1311-1315
  2. Warren JR, Marshall B. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 321: 1273-1275
  3. Hunt RH. 1996. Eradication of Helicobacter pylori infection. Am J Med 100(5A): 42S-50S
  4. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL. 1999. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116: 804-812
  5. Chakravarti DN, Fiske MJ, Fletcher LD, Zagursky RJ, 2000. Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates. Vaccine 19: 601-612
  6. Kim BJ, Kang JH, Kim TY, Kim TH, Kim KW. 1997. Production and characterization of IgY specific to Helicobacter pylori. Kor J Appl Microbiol Biotechnol 25: 612-616
  7. Mysore JV, Wigginton T, Simon PM, Zopf D, HemanAckam LM, Dubois A. 1999. Treatment of Helicobacter pylori infection in Rhesus monkeys using a novel anti adhesion compound. Gastroenterology 117: 1316-1325
  8. Simon PM, Goode PL, Mobasseri A, Zopf D. 1997. Inhibition of Helicobacter pylori vinding to gastrointestinal infect. Immun 65: 750-757
  9. Mabe K, Yamada M, Oguni I, Takahashi T. 1999. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 43: 1788-1791
  10. Mobley HL, Jarvis KG, Elwood JP. 1993. Osogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol 10: 143-155
  11. Roe IH, Nam SW, Yang MR, Myung NH, Kim JT, Shim JY, 2002. The promising effect of egg yolk antibody (immunoglobulin yolk) on the treatment of Helicobacter pylori-associated gastric diseases. Kor J Gastroenterology 39: 260-268
  12. Early EM, Hady H. 2001. Bactericidal effect of a whey protein concentrate with anti-Helicobacter pylori activity. J Appl Microbiol 90: 741-748
  13. Brussow H, Hildert H. 1987. Bovine milk immunoglobulins for passive immunity to infantile Rotavirus gastroenteritis. J Clin Microbiol 25: 982-986
  14. Lee KA. 1996. Studies on the stability of Hen's egg yolk immunoglobulins. Kor J Soc Food Sci 12: 54-59
  15. 김현욱. 1998. 낙농화학. 선진문화사, 서울. p 84-85, 99-106
  16. 김태규, 박수정, 서영훈, 신동건, 엄현석, 이정림, 정낙균, 정대철, 정태준, 진종류, 한치화. 2002. 면역생물학. 제5판. 라이프 사이언스, 서울. p 96-98
  17. Shin NR, Kim JM, Yoo HS. 2001. Control of swine respiratory disease using egg yolk antibodies ill. Immunoprophylactic effect of IgY in mouse model. Kor J Vet Res 41: 351-356
  18. Mulcahy G, O'Connor F, McGonigle S, Dowd A, Clery DG, Andrews SJ, Dalton JP. 1998. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 16: 932-939
  19. Chen CC, Tu YY, Chang HH. 2000. Thermal stability of bovine milk immunoglobulin G (IgG) and the effect of added thermal protectants on the stability. J Food Sci 65: 188-193
  20. 김우호. 1993. 면역에 묘한 생체방어와 생명유지의 기구. 강원대학교출판부, 춘천. p 50-60
  21. Morales FJ, Romero C, Jimenez-Perez S. 2000. Characterization of industrial processed milkly analysis of heat-indued change. Int J Food Sci Technol 35: 193-200